In PDAC, the activation of Kras promotes the production of inflammatory cytokines, including IL-1, which activates NF-κB to promote tumor cell survival and proliferation, increased invasive and metastatic behavior, and angiogenesis [5,12,13,14]. Here, IL1B is linked to neoplasm.